you for start, I'll summary XXXX. quarter dive performance accomplishments today.
To Thanks, and in give Then joining results. all with first the into notable and recent our Shameze of Mark, thank financial of our will a us
Following that, I'll floor lies the us you finally, for may open of discuss have. any questions what XXXX. in ahead we'll And
regarding terms, First, nonbinding I'd of into In on would an stock provide like to outstanding attend entered common in potential Under a the systems. share proposed per company. for stores $X.XX intent of recent update April, letter cash. development a the acquire we a acquisition of car our XXX% for with STORZ early KARL
robotics state-of-the-art provides the broader KARL and clinical of ISU. presence with operating adoption of our KARL digital global this to group. an potential resources STORZ' deliver attractive scale to value digital combined commercial and by solutions unmatched the STORZ is global LUNA minimally and medical a believe specialties. procedures various leader effectiveness. for As clinical precision surgical and state-of-the-art company a and reminder, across a STORZ devices medical in strong with offering an instruments, that endoscopes, global to design, We industry, visionary opportunity coupled and enable could and solutions craftsmanship STORZ maximize KARL surgery capabilities acquisition is the committed is technology and KARL family-owned the presence invasive independent potential
and As is agreement. and diligence conduct exclusivity merger period previously STORZ definitive ongoing. started negotiate on March due a XX, to we XX-week XXXX, have exclusivity a period KARL disclosed, This granted
we announcing agreement be $XX if support will negotiated the definitive diligence our been providing operations have necessary closely a Since pursue KARL working due up we period, facilitate STORZ their exclusivity April approvals. process. us note merger the X, to as additional all is in KARL million $XX STORZ with on us to available million fully to potential secured promissory During with and transaction financing and a and successfully is through executed to
which As To tranche make committee. the the of liquidity today, note, million we recommendation formed for provided have board a a drawn the of has evaluate stockholders, first the potential of terms $X operations. transaction has our the of million and to transaction $XX
activities, our merger in will acquisition.
Further particular, While we will ongoing interest on Senhance there's continued this first we pediatric system stockholders. STORZ, clinical X-millimeter the procedures that unit approval completed, LUNA stockholder future. as the are in to expeditiously these capturing KARL valuable the uniquely be of opportunity was of agreement With nearly no the the able to X-millimeter be our secure updates and system delicate the improved growth STORZ we in ISU. transaction diligence data the development Senhance is we move of surgeons with proposed for the the system the business KARL focused and the If remain machine procedures. allowing instruments, learning the Despite used and worldwide. and assurance system through increasingly ongoing the surgical will provided intelligent to finalize believe for the us exploring appropriate. is capabilities Senhance company nature our insights of definitive continually with best to provide from quarter, and In surgical XXX By surgeries, designed in specialized
minimally unique and the performed expect sensor's procedures the not to and recognize of number surgery, grow. invasive digital continue system the solutions, advances with which surgeons robotics preserve we using Senhance only design, pediatric also to pediatric but ISU surgery more laparoscopy As
of represents into of of Japan's in the to adopt capabilities Japanese the market.
In adoption of to Hospital Senhance in institution I technology. to Moving entered our and quarter as surgical utilize our of solutions progress in digital growth platform. systems systems. April, the one steady summary, Senhance within Senhance saw in we view further validation in the this system the In the private largest our program trust new continued surgery one enhancing first Sendai This growing the second initiations. agreement hospital lease and our that announced an Tokushukai Japan
are We the our with of KARL potential to opportunity mission accelerate join about surgical STORZ excited environment. the forces digitizing to
on and potential new a our clinical team for our advancing to XXXX.
With a transaction, initiations, towards driving for development. work initiatives we including executing continued momentum platform our adoption registry key we like our well program Shameze over expanding remains believe are focused update. I in turn volumes, LUNA call positioned would that, While increasing through proceeds We further against to the financial